Working… Menu

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor (RESPITE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02007629
Recruitment Status : Completed
First Posted : December 11, 2013
Last Update Posted : February 21, 2019
Information provided by (Responsible Party):